Landon Clay

Golden Queen Mining Consolidated Ltd. is engages in the engages in the exploration of gold and mineral properties. The company was founded on November 21, 1985 and is headquartered in Vancouver, Canada.

Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA.

Arradiance LLC develops maskless, massively parallel and direct-write e-beam source products. It combines material science, charged particle physics, equipment design, modeling, simulation and vacuum technology. The company was founded by Harry F. Lockwood, Kenneth Stenton and David R. Beaulieu in 2003 and is headquartered in Sudbury, MA.

Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK.

The Museum of Fine Arts, Boston houses and preserves preeminent collections and serves a variety of people through direct encounters with works of art. It conducts exhibitions, programs and research and publication activities and interprets its own collections. It provides information and perspective on art through time and throughout the world. The museum holds its collections in trust for future generations. The Museum’s collection is made up of: Art of the Americas, Art of Europe, Contemporary Art, Art of Asia, Oceania and Africa, Art of the Ancient World, Prints, Drawings and Photographs, Textiles and Fashion Arts and Musical Instruments.

Oxitec Ltd. develops solutions for controlling harmful insect pests. It provides biological and development research services in controlling insects that spread diseases and damage crops. Its products include Diamond back moth, Pink bollworm, Medfl,y Mexfly, and Olive fly. The company was founded by Luke Alphey on August 15, 2002 and is headquartered in Abingdon, the United Kingdom.

Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK